Literature DB >> 9134425

Differential expression of LacdiNAc sequences (GalNAc beta 1-4GlcNAc-R) in glycoproteins synthesized by Chinese hamster ovary and human 293 cells.

K Y Do1, S I Do, R D Cummings.   

Abstract

The lacdiNAc sequence GalNAc beta 1-->4GlcNAc beta 1-R occurs in the N- and O-glycans of many glycoproteins in vertebrate and invertebrates. We now report that both human 293 cells and Chinese hamster ovary (CHO) cells contain a UDPGalNAc:GlcNAc beta 1,4 N-acetylgalactosaminyltransferase (beta 1,4GalNAcT) that forms the lacdiNAc sequence. The beta 1,4GalNAcT in CHO cells is distinct from beta 1,4 galactosyltransferase in that the latter enzyme, but not the former, binds to a column of immobilized bovine alpha-lactalbumin. To determine whether endogenous glycoproteins in these cells contain lacdiNAc sequences, glycoproteins from 293 cells, CHO and Lec8 CHO cells were desialylated and passed over immobilized Wisteria floribunda agglutinin (WFA), a plant lectin with affinity for terminal GalNAc residues. WFA bound to approximately 120 and approximately 80 kDa glycoproteins in 293 cells and glycans from these glycoproteins contained lacdiNAc sequences. The approximately 120 kDa glycoproteins in 293 cells bound by WFA is a mixture of both the lysosome-associated membrane glycoproteins LAMPs-1 and -2. WFA bound to two glycoproteins of approximately 47 and approximately 78 kDa in Lec8 CHO cells, but these glycoproteins are not LAMPs and they do not contain the lacdiNAc sequence. Instead, they contain multiple GalNAc alpha-Ser/Thr O-glycans that promote binding to WFA. Thus, the beta 1,4GalNAcT in 293 cells displays a limited specificity in its recognition of acceptors, whereas the beta 1,4GalNAcT in CHO cells fails to promote synthesis of the cognate lacdiNAc sequence. The presence of the beta 1,4GalNAcT may not be sufficient for synthesis of lacdiNAc sequences and other factors may contribute to regulate the functionality of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9134425     DOI: 10.1093/glycob/7.2.183

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  16 in total

1.  Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells.

Authors:  Z Zheng; R D Cummings; P E Pummill; P W Kincade
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Priming mass spectrometry-based sulfoglycomic mapping for identification of terminal sulfated lacdiNAc glycotope.

Authors:  Shin-Yi Yu; Lan-Yi Chang; Chu-Wen Cheng; Chi-Chi Chou; Michiko N Fukuda; Kay-Hooi Khoo
Journal:  Glycoconj J       Date:  2012-06-01       Impact factor: 2.916

3.  Peptide-specific transfer of N-acetylgalactosamine to O-linked glycans by the glycosyltransferases β1,4-N-acetylgalactosaminyl transferase 3 (β4GalNAc-T3) and β4GalNAc-T4.

Authors:  Dorothy Fiete; Mary Beranek; Jacques U Baenziger
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

4.  Systems glycomics of adult zebrafish identifies organ-specific sialylation and glycosylation patterns.

Authors:  Nao Yamakawa; Jorick Vanbeselaere; Lan-Yi Chang; Shin-Yi Yu; Lucie Ducrocq; Anne Harduin-Lepers; Junichi Kurata; Kiyoko F Aoki-Kinoshita; Chihiro Sato; Kay-Hooi Khoo; Ken Kitajima; Yann Guerardel
Journal:  Nat Commun       Date:  2018-11-07       Impact factor: 14.919

5.  N-Glycosylation is required for secretion of the precursor to brain-derived neurotrophic factor (proBDNF) carrying sulfated LacdiNAc structures.

Authors:  Julius Benicky; Miloslav Sanda; Zuzana Brnakova Kennedy; Radoslav Goldman
Journal:  J Biol Chem       Date:  2019-09-26       Impact factor: 5.157

6.  O-linked N,N'-diacetyllactosamine (LacdiNAc)-modified glycans in extracellular matrix glycoproteins are specifically phosphorylated at subterminal N-acetylglucosamine.

Authors:  Isabelle Breloy; Sandra Pacharra; Philipp Ottis; David Bonar; Ammi Grahn; Franz-Georg Hanisch
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

7.  Identification of mammalian glycoproteins with type-I LacdiNAc structures synthesized by the glycosyltransferase B3GALNT2.

Authors:  Takahiro Nakane; Kiyohiko Angata; Takashi Sato; Hiroyuki Kaji; Hisashi Narimatsu
Journal:  J Biol Chem       Date:  2019-03-21       Impact factor: 5.157

8.  Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.

Authors:  Xiaotian Zhong; Srinath Jagarlapudi; Yan Weng; Mellisa Ly; Jason C Rouse; Kim McClure; Tetsuya Ishino; Yan Zhang; Eric Sousa; Justin Cohen; Boriana Tzvetkova; Kaffa Cote; John J Scarcelli; Keith Johnson; Joe Palandra; James R Apgar; Suma Yaddanapudi; Romer A Gonzalez-Villalobos; Alan C Opsahl; Khetemenee Lam; Qing Yao; Weili Duan; Annette Sievers; Jing Zhou; Darren Ferguson; Aaron D'Antona; Richard Zollner; Hongli L Zhu; Ron Kriz; Laura Lin; Valerie Clerin
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

9.  Novel induction of alpha-lactalbumin-mediated lacdiNAc-R expression in vivo.

Authors:  S I Do; K Y Lee; H N Kim
Journal:  Biochem J       Date:  2000-05-15       Impact factor: 3.857

10.  Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[β1→4]GlcNAc), by Wisteria floribunda Agglutinin.

Authors:  Omid Haji-Ghassemi; Michel Gilbert; Jenifer Spence; Melissa J Schur; Matthew J Parker; Meredith L Jenkins; John E Burke; Henk van Faassen; N Martin Young; Stephen V Evans
Journal:  J Biol Chem       Date:  2016-09-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.